Pioglitazone with sulfonylurea: Glycemic and lipid effects in Taiwanese type 2 diabetic patients

Diabetes Research and Clinical Practice

Volumn 70, Issue 2, 2005, Pages 193-194

  Tseng, Chin Hsiao ^a,b,c   Huang, Tien Shang ^a,b  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^c NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PIOGLITAZONE; SULFONYLUREA; TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; COMORBIDITY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COUGHING; DIABETES CONTROL; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; LIPOPROTEIN BLOOD LEVEL; LIVER TOXICITY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PROTEIN BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL; TRIACYLGLYCEROL BLOOD LEVEL; VIRUS HEPATITIS;

ADULT; AGED; BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 2; DOUBLE-BLIND METHOD; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; HYPOGLYCEMIC AGENTS; LIPIDS; MALE; MIDDLE AGED; SULFONYLUREA COMPOUNDS; TAIWAN; THIAZOLIDINEDIONES;

EID: 25444532528     PISSN: 01688227     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diabres.2004.11.003     Document Type: Article

References (6)

1. M.S. Kipnes, A. Krosnick, M.S. Rendell, J.W. Egan, A.L. Mathisen, and R.L. Schneider Pioglitazone hydrochloride in combination with sulfonylurea therapy improves glycemic control in patients with type 2 diabetes mellitus: a randomized, placebo-controlled study Am. J. Med. 111 2001 10 17
2. D. Einhorn, M. Rendell, J. Rosenzweig, J.W. Egan, A.L. Mathisen, and R.L. Schneider Pioglitazone hydrochloride in combination with metformin in the treatment of type 2 diabetes mellitus: a randomized, placebo-controlled study, the Pioglitazone 027 Study Group Clin. Ther. 22 2000 1395 1409
3. S. Aronoff, S. Rosenblatt, S. Braithwaite, J. Egan, A. Mathisen, R. Schneider the Pioglitazone 001 Study Group Pioglitazone hydrochloride monotherapy improves glycemic control in the treatment of patients with type 2 diabetes Diabetes Care 23 2000 1605 1611
4. A.B. King, and D.U. Armstrong Lipid response to pioglitazone in diabetic patients: clinical observations from a retrospective chart review Diabetes Technol. Ther. 4 2002 145 151
5. M.A. Khan, J.V. St Peter, and J.L. Xue A prospective, randomized comparison of the metabolic effects of pioglitazone or rosiglitazone in patients with type 2 diabetes who were previously treated with troglitazone Diabetes Care 25 2002 708 711
6. G. Derosa, A.F.G. Cicero, A. Gaddi, P.D. Ragonesi, E. Fogari, and G. Bertone Metabolic effects of pioglitazone and rosiglitazone in patients with diabetes and metabolic syndrome treated with glimepiride: a twelve-month, multicenter, double-blind, randomized, controlled, parallel-group trial Clin. Ther. 26 2004 744 754